Medtronic, Inc. Announces Exclusive Licensing of Arbor Surgical Technologies Pericardial Heart Valve
Published: Jan 28, 2008
MINNEAPOLIS & IRVINE, Calif.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) and Arbor Surgical Technologies, Inc. today announced an exclusive global licensing agreement under which Medtronic will manufacture, market and distribute Arbor’s bovine pericardial tissue heart valve technologies. In addition, Medtronic has acquired a minority stake in Arbor. Arbor retains its exclusive rights to the modular Trilogy™ Aortic Valve System and sutureless TRE™ implantation technologies.